Fulgent Genetics, Inc.
FLGT
$14.63
$0.382.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 322.67M | 315.55M | 303.22M | 292.45M | 283.47M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 322.67M | 315.55M | 303.22M | 292.45M | 283.47M |
| Cost of Revenue | 191.80M | 185.41M | 181.82M | 178.99M | 176.26M |
| Gross Profit | 130.88M | 130.14M | 121.40M | 113.46M | 107.22M |
| SG&A Expenses | 158.11M | 141.29M | 136.39M | 127.63M | 124.35M |
| Depreciation & Amortization | 8.03M | 8.00M | 7.97M | 7.97M | 7.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 411.84M | 386.54M | 375.95M | 364.36M | 357.39M |
| Operating Income | -89.17M | -70.99M | -72.72M | -71.92M | -73.92M |
| Income Before Tax | -70.03M | -48.80M | -59.82M | -49.51M | -51.96M |
| Income Tax Expenses | -8.39M | -4.63M | -7.78M | -7.64M | -8.14M |
| Earnings from Continuing Operations | -61.63 | -44.17 | -52.04 | -41.87 | -43.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.12M | 1.19M | 1.02M | 1.10M | 1.11M |
| Net Income | -60.51M | -42.98M | -51.02M | -40.78M | -42.71M |
| EBIT | -89.17M | -70.99M | -72.72M | -71.92M | -73.92M |
| EBITDA | -65.05M | -46.79M | -48.64M | -47.73M | -48.99M |
| EPS Basic | -1.97 | -1.40 | -1.67 | -1.34 | -1.42 |
| Normalized Basic EPS | -1.14 | -0.75 | -0.78 | -0.77 | -0.83 |
| EPS Diluted | -1.97 | -1.40 | -1.67 | -1.34 | -1.42 |
| Normalized Diluted EPS | -1.14 | -0.75 | -0.78 | -0.77 | -0.83 |
| Average Basic Shares Outstanding | 123.11M | 122.78M | 122.44M | 122.00M | 120.94M |
| Average Diluted Shares Outstanding | 123.11M | 122.78M | 122.44M | 122.00M | 120.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |